BYJOINING US FOR                                                  A VERY SPECIAL GUEST LECTURE BY:                     

                             RANDI HAGERMAN, MD                                                                                                                                              Our Esteemed colleague and mentor                                                                                                Medical Director, UC Davis MIND Institute, Distinguished Professor, Endowed Chair in Fragile X Research,                                                   Department of Pediatrics, UC Davis School of Medicine 

                 "Lessons Learned and Best Practices in                                         Neurodevelopmental Disorders:                            The Case for Multidisciplinary Collaborative Care"


Be our guest at this free event


Friday, September 14, 2018             2 - 4pm MST


University of Denver: DU Commons (Room KRH-106)

The Commons is location in Katherine A. Ruffatto Hall (Ruffatto Hall) on the 1st floor near the main north entrances.  Ruffatto Hall is located on the North East corner of the High St. & Evans Ave. interchange.

 PARKING: The closest pay parking lot to Ruffatto would be lot 301 (Teal Star). Lot 301 is located directly to the south of Ruffatto Hall across Evans Ave.

Please note: Lot 302, 316W, 316E and K are no longer parking lots due to ongoing construction.


Mouse Scharfenaker
Developmental FX

    We would like to thank Dr Hagerman for inspiring countless      scientists, clinicians, parents and educators to

collaborate in sharing information about

best practice in a multidisciplinary setting


ABOUT DR. HAGERMAN                                                                                                                    Dr. Randi Hagerman is a developmental and behavioral pediatrician and the Medical Director of the MIND Institute at UC Davis.  She is internationally recognized as both a clinician and researcher in the fragile X field.  Dr. Hagerman received her M.D. from Stanford University where she also carried out her Pediatric residency.  She completed a Fellowship in Learning and Disabilities and Ambulatory Pediatrics at UC San Diego and, subsequently, spent the next 20 years from 1980 to 2000 at the University of Colorado where she headed Developmental and Behavioral Pediatrics.  She co-founded the National Fragile X Foundation in 1984 in Colorado and developed a world-renowned fragile X research and treatment center.  In 2000, Professor Hagerman moved to UC Davis to be the Medical Director of the MIND Institute.  Dr. Hagerman and her team discovered the Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) which is a neurological disorder that affects older male and rare female carriers of fragile X.  Dr. Hagerman’s research involves genotype-phenotype correlations in fragile X and she carries out this research in collaboration with her husband, Paul Hagerman, M.D., Ph.D.  Professor Randi Hagerman has written over 200 peer-reviewed articles and numerous book chapters on neurodevelopmental disorders.  She has written several books on fragile X including a 3rd Edition of Fragile X Syndrome: Diagnosis, Treatment, and Research which was published in 2002 by Johns Hopkins University Press.  Dr. Hagerman has received numerous awards for her research in fragile X syndrome including the Jerrett Cole Award from the National Fragile X Foundation for unselfish dedication to work with fragile X children and adults, the Bonfils-Stanton Foundation Award for Science including Medicine, the IASSID Distinguished Achievement Award for Scientific Literature, the 2005 Distinguished Scholarly Public Service Award from UC Davis, and the 2006 Dean’s Award for Outstanding Mentoring at UC Davis.  In 2004, to honor both Randi and Paul Hagerman in recognition of their work in FXTAS, the National Fragile X Foundation established the Hagerman Award.  This award recognizes research accomplishments in the field of FXTAS and is given at the bi-annual International Conference on Fragile X.  In 2008, the National Fragile X Foundation again honored Dr. Hagerman with a Lifetime Achievement Award. Dr. Hagerman has worked internationally to establish fragile X clinical programs and research programs throughout the world.  Dr Hagerman is currently carrying out multiple targeted treatment trials in FXS and in autism including a controlled trial of Arbaclofen, minocycline, ganaxolone, mGluR5 antagonists developed by Roche and another by Novartis, and sertraline. She is also the PI of a controlled trial of memantine in older fragile X premutation carriers with FXTAS.


This event is jointly sponsored by:





About Us:

Our mission is to transform the lives of children and families affected by learning and developmental disorders so that they can live to their fullest potential.

Our clinicians create and implement best practices with individualized and multi-disciplinary therapies for children with a wide range of learning and developmental disabilities – ‘Therapy That Fits.”

In order to reach as many families and clinicians as possible, we actively provide local, national, and worldwide training and mentoring in DFX’s methods and best practices.

Our involvement in internationally recognized collaborations, research, and publications ensures our continued growth and provision of the best “Therapy That Fits” to each of the children and families we serve.

Overview of our approach:

We've all encountered struggling kids who need more help than we can provide, who need different tools and expertise than are readily available. These are the individuals who don't fit the standard, compartmentalized processes. These are the individuals we specialize in--we understand them, know what they need and how to facilitate their optimal wellbeing and development. 

We do this by treating every child comprehensively and uniquely - unique to their resources, strengths, and challenges.  And we do this by understanding that every child is a member of a family, a classroom, a community. So, we wrap-our-services-around all of this to ensure positive outcomes. 

A Leading Resource

More than just helping kids with a wide-range of challenges, we train therapists, physicians, teachers and families around the world.  We are advancing the state of the art in overcoming developmental challenges, and we are growing the skills of the people who care for these special kids.